DK0625351T3 - Anvendelse af etofibrat og farmaceutiske præparater indeholdende etofibrat til behandling af diabetisk angio- og retinopati - Google Patents

Anvendelse af etofibrat og farmaceutiske præparater indeholdende etofibrat til behandling af diabetisk angio- og retinopati

Info

Publication number
DK0625351T3
DK0625351T3 DK94106819T DK94106819T DK0625351T3 DK 0625351 T3 DK0625351 T3 DK 0625351T3 DK 94106819 T DK94106819 T DK 94106819T DK 94106819 T DK94106819 T DK 94106819T DK 0625351 T3 DK0625351 T3 DK 0625351T3
Authority
DK
Denmark
Prior art keywords
etofibrate
retinopathy
treatment
pharmaceutical preparations
preparations containing
Prior art date
Application number
DK94106819T
Other languages
English (en)
Inventor
Hans Dr Med Erbler
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Application granted granted Critical
Publication of DK0625351T3 publication Critical patent/DK0625351T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94106819T 1993-05-19 1994-05-02 Anvendelse af etofibrat og farmaceutiske præparater indeholdende etofibrat til behandling af diabetisk angio- og retinopati DK0625351T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4317127A DE4317127A1 (de) 1993-05-19 1993-05-19 Verwendung von Etofibrat und pharmazeutische Zusammensetzungen, enthaltend Etofibrat, zur Behandlung der diabetischen Angio- und Retinopathie

Publications (1)

Publication Number Publication Date
DK0625351T3 true DK0625351T3 (da) 1999-08-30

Family

ID=6488713

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94106819T DK0625351T3 (da) 1993-05-19 1994-05-02 Anvendelse af etofibrat og farmaceutiske præparater indeholdende etofibrat til behandling af diabetisk angio- og retinopati

Country Status (7)

Country Link
EP (1) EP0625351B1 (da)
AT (1) ATE175349T1 (da)
DE (2) DE4317127A1 (da)
DK (1) DK0625351T3 (da)
ES (1) ES2126015T3 (da)
GR (1) GR3029898T3 (da)
SI (1) SI0625351T1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5134818B2 (ja) * 2003-07-02 2013-01-30 アボット・ラボラトリーズ 脂質制御薬物製剤の製造のための方法
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1941217C3 (de) * 1969-08-13 1974-06-12 Merz & Co, 6000 Frankfurt Alpha- eckige Klamer auf 2-(p-Chlorphenoxy)-isobutyryril eckige Klammer zu-beta-nicotinoylglykolester und Verfahren zu seiner Herstellung
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
DE3621861A1 (de) * 1986-06-30 1988-01-14 Laszlo Dr Med Ilg Verwendung von aryloxycarbonsaeure-derivaten gegen dermatologische erkrankungen
DE4021678C2 (de) * 1990-07-07 1994-07-07 Merz & Co Gmbh & Co Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen

Also Published As

Publication number Publication date
ATE175349T1 (de) 1999-01-15
DE4317127A1 (de) 1994-11-24
EP0625351B1 (de) 1999-01-07
GR3029898T3 (en) 1999-07-30
DE59407576D1 (de) 1999-02-18
EP0625351A1 (de) 1994-11-23
ES2126015T3 (es) 1999-03-16
SI0625351T1 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
DK552684A (da) Desulfatohirudiner samt deres fremstilling og anvendelse
DE68912237D1 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
NO177374C (no) Stabile preparater av fettlöselige substanser og anvendelse av fiskegelatin ved fremstilling derav
SE8700498D0 (sv) Novel pharmaceologically active compounds
DK573384D0 (da) Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater
ATE101517T1 (de) Pharmazeutische zusammensetzung, enthaltend loratadin, ibuprofen und pseudoephedrin.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
DK0404283T3 (da) 11alfa-aryl-4-estrener, fremgangsmåde til fremstilling af disse samt deres anvendelse som lægemidler
DE3867659D1 (de) 1,5-diphenyl-1h-1,2,4-triazol-3-carboxamid-derivate und diese enthaltende herbizide zusammensetzungen.
DK0508220T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstiling, deres anvendelse og midler med in dhold deraf
IL98917A0 (en) Piperidyl ethers and thioethers and their use as inhibitors of cholesterol biosynthesis
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DK47885D0 (da) Kompositioner til brug som kosmetiske, sundhedsbevarende og kropsbeskyttende midler
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
DE68921908D1 (de) Zell-assoziierte Glucosyltransferase, Antikörper dagegen und eine diese enthaltende Zusammensetzung zur Prophylaxe von Karies.
SE8600658D0 (sv) Novel composition of matter
DK0533408T3 (da) Kosmetik og farmaceutika indeholdende extensiner
DE69224836D1 (de) Optisch aktive tetrahydropyran derivate, flüssigkristallzusammensetzungen und diese enthaltende flüssigkristallelemente
DK0625351T3 (da) Anvendelse af etofibrat og farmaceutiske præparater indeholdende etofibrat til behandling af diabetisk angio- og retinopati
DE68905973D1 (de) Synergistische suessungsmittel-zusammensetzungen, enthaltend chlorodeoxysucrase, und diese enthaltende zusammensetzungen.
DE3068880D1 (en) Carbamates, their preparation and pharmaceutical compositions containing them
DK78788D0 (da) 4-substituerede benzamid-derivater og farmaceutiske midler indeholdende saadanne derivater
DK330687A (da) Forbindelser og farmaceutiske kompositioner, der er anvendelige som cardiotoniske midler
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
FR2658810B1 (fr) Composition contenant des oligo-elements et procedes mettant en óoeuvre cette composition.